Home › Pharmacology › Alpha-Blockers

Alpha-Adrenergic Blockers

Q: Which alpha-blockers are used to manage hypertensive emergencies?

Proroxan is used to manage hypertensive crises. Proroxan (Proroxan) is a drug that blocks central and peripheral $\alpha_1$- and $\alpha_2$-adrenoceptors. This leads to peripheral vasodilation (primarily arterioles and precapillaries) and a decrease in blood pressure. The drug is also used for sympathoadrenal crises associated with hypothalamic syndrome.

For medical students2 min readUpdated 2026-10-10

Alpha-blockers (alpha-adrenergic antagonists) are a group of peripheral neurotropic antihypertensive drugs. They prevent the binding of sympathetic nervous system neurotransmitters to vascular adrenoceptors, leading to prominent vasodilation and a reduction in blood pressure.

First-dose effectA sharp drop in blood pressure with the first dose due to blood pooling in the veins.

ComorbidityDrugs of choice for concurrent hypertension and benign prostatic hyperplasia (BPH).

LimitationNon-selective blockers are no longer used for essential hypertension.

Side effectBlood pressure reduction is frequently accompanied by reflex tachycardia.

Selective $\alpha_1$-Blockers

This group includes drugs such as prazosin (Minipress), doxazosin (Cardura), and terazosin. Doxazosin is distinguished as a long-acting agent.

Their main target is postsynaptic $\alpha_1$-adrenoceptors located in blood vessels. By blocking these receptors, the drugs completely eliminate the stimulatory influence of the sympathetic nervous system on vascular tone.

Hemodynamic effects:

In arterioles (resistance vessels): the lumen dilates, total peripheral resistance (TPR) drops, and consequently, blood pressure decreases.
In veins (capacitance vessels): dilation leads to a drop in venous pressure, significantly reducing cardiac preload.

Compensatory Reactions and Side Effects

The antihypertensive effect of $\alpha_1$-blockers inevitably triggers a cascade of reflex regulatory mechanisms as the body attempts to compensate for the drop in pressure:

Reflex tachycardia. Initiated by baroreceptors that detect vasodilation and trigger a moderate increase in heart rate.
RAAS activation. Due to reduced blood supply (perfusion) to the renal parenchyma, renin secretion is compensatorily increased.
Orthostatic (postural) hypotension. Upon rapidly standing up, blood pools in the dilated veins, causing a sudden drop in blood pressure. This phenomenon is most pronounced with the very first dose, referred to in clinical pharmacology as the "first-dose effect".

Use in Comorbid Conditions

Selective $\alpha_1$-blockers offer a unique advantage in treating comorbid patients. They are the drugs of choice when arterial hypertension is combined with benign prostatic hyperplasia (BPH).

This clinical benefit stems from the drugs' ability to relax the smooth muscle of the prostatic urethra and the bladder neck. Consequently, patient spasm is relieved, and urination is significantly facilitated. It is important to note that other antihypertensive agents (e.g., calcium channel blockers like diltiazem, verapamil, and amlodipine) do not affect prostate receptors.

Non-Selective Agents and Pheochromocytoma

Non-selective $\alpha_1$- and $\alpha_2$-blockers include phentolamine and phenoxybenzamine. Today, they are not used to treat standard (essential) hypertension for two main reasons:

Short duration of action. Blockade of presynaptic $\alpha_2$-receptors disrupts the negative feedback mechanism, increasing norepinephrine release.
Pronounced tachycardia. This occurs via two mechanisms: reflexively (in response to lowered blood pressure) and directly (by removing the "brake" on neurotransmitter release in the heart).

However, phentolamine is indispensable in diagnosing and treating secondary arterial hypertension caused by pheochromocytoma—an adrenal tumor that secretes epinephrine and norepinephrine.

Here, the drug induces the phenomenon of "epinephrine reversal". Phentolamine blocks postsynaptic $\alpha_1$-receptors and extrasynaptic $\alpha_2$-receptors in blood vessels. Against the background of such total $\alpha$-blockade, circulating epinephrine can stimulate only $\beta_2$-adrenoceptors. Result: instead of expected vasoconstriction, vasodilation and a drop in pressure occur.

Mnemonic

To understand epinephrine reversal in pheochromocytoma, imagine a scale with two pans: $\alpha$ (vasoconstriction) and $\beta_2$ (vasodilation). Phentolamine tightly locks the $\alpha$ pan, so all circulating epinephrine presses solely on the $\beta_2$ pan, forcing vessels to dilate.

Frequently asked questions

Which alpha-blockers are used to manage hypertensive emergencies?

Proroxan is used to manage hypertensive crises.

Proroxan (Proroxan) is a drug that blocks central and peripheral $\alpha_1$- and $\alpha_2$-adrenoceptors. This leads to peripheral vasodilation (primarily arterioles and precapillaries) and a decrease in blood pressure. The drug is also used for sympathoadrenal crises associated with hypothalamic syndrome.

What are the bioavailability and half-life of doxazosin?

The bioavailability of doxazosin is 60–70%, and its half-life is 19–22 hours.

The drug exhibits good systemic absorption when taken orally (80–90%), but undergoes presystemic hepatic metabolism (first-pass effect), which reduces its final bioavailability. Its long half-life allows for convenient once-daily dosing. Doxazosin is extensively metabolized in the liver, with metabolites excreted primarily via the feces.

Which drugs are classified as uroselective alpha-1-blockers?

Tamsulosin and alfuzosin are uroselective $\alpha_1$-blockers.

These drugs are used for benign prostatic hyperplasia:

Tamsulosin — provides selective blockade of $\alpha_{1A}$-adrenoceptors in the smooth muscle of the prostate and bladder neck.
Alfuzosin — also used for benign prostatic hyperplasia.

Tamsulosin does not significantly affect vascular tone or systemic blood pressure.

Why do non-selective alpha-blockers cause severe tachycardia?

They block presynaptic $\alpha_2$-receptors, impairing negative feedback. This removes the "brake" on norepinephrine release, which directly stimulates the heart, compounded by reflex tachycardia in response to the drop in blood pressure.

What is the "first-dose effect"?

It is a sharp drop in blood pressure (orthostatic hypotension) upon assuming an upright position. The phenomenon occurs due to venous dilation and blood pooling, manifesting most prominently after the very first dose of the drug.

How do alpha-blockers help with BPH?

They relax the smooth muscle of the bladder neck and the prostatic urethra. This removes the obstruction to urine outflow and facilitates urination in comorbid patients.

Can the effects of doxazosin and nebivolol be confused?

No, because they belong to different pharmacological groups. Doxazosin (an $\alpha_1$-blocker) causes reflex tachycardia in response to vasodilation, whereas nebivolol (a $\beta$-blocker) lowers heart rate, causing bradycardia.

Go deeper

Detailed mechanism of the baroreceptor reflex during drug-induced vasodilation.
The role of renin and RAAS activation in response to reduced renal perfusion.
Functional differences between presynaptic and postsynaptic adrenoceptors.
Pharmacodynamics of epinephrine during isolated interaction with vascular $\beta_2$-receptors.
Differential diagnosis of antihypertensive agents (distinguishing from calcium channel blockers).